← Open Payments lookup

LUKE GREENE: Open Payments

NPI 1134423056 · CHEHALIS, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$845 in 26 payments from 10 companies in 2025. Trend: 2023 $67 · 2024 $50 · 2025 $845

Food & beverage: $845
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.3$182
E.R. Squibb & Sons, L.L.C.2$155
Axsome Therapeutics, Inc.4$108
Alkermes, Inc.4$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$85
Teva Pharmaceuticals USA, Inc.2$70
ABBVIE INC.3$56
Lundbeck LLC2$45
Otsuka America Pharmaceutical, Inc.1$30
Neurocrine BioSciences, Inc.1$20

Products named: FANAPT, COBENFY, ARISTADA, CAPLYTA, Auvelity, REXULTI, AUSTEDO XR, VRAYLAR.

Industry payments across WA — which companies pay providers there.